Early Effects of Metabolic Syndrome on ATP-Sensitive Potassium Channels from Rat Pancreatic Beta Cells. 2022

Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
Neuroscience Division, Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad Universitaria, AP 70-253 Coyoacán, México City 04510, Mexico.

Metabolic syndrome (MS) is a cluster of metabolic signs that increases the risk of developing type 2 two diabetes mellitus and cardiovascular diseases. MS leads to pancreatic beta cell exhaustion and decreased insulin secretion through unknown mechanisms in a time-dependent manner. ATP-sensitive potassium channels (KATP channels), common targets of anti-diabetic drugs, participate in the glucose-stimulated insulin secretion, coupling the metabolic status and electrical activity of pancreatic beta cells. We investigated the early effects of MS on the conductance, ATP and glybenclamide sensitivity of the KATP channels. We used Wistar rats fed with a high-sucrose diet (HSD) for 8 weeks as a MS model. In excised membrane patches, control and HSD channels showed similar unitary conductance and ATP sensitivity pancreatic beta cells in their KATP channels. In contrast, MS produced variability in the sensitivity to glybenclamide of KATP channels. We observed two subpopulations of pancreatic beta cells, one with similar (Gly1) and one with increased (Gly2) glybenclamide sensitivity compared to the control group. This study shows that the early effects of MS produced by consuming high-sugar beverages can affect the pharmacological properties of KATP channels to one of the drugs used for diabetes treatment.

UI MeSH Term Description Entries

Related Publications

Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
June 1992, British journal of pharmacology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
February 1995, The American journal of physiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
March 2000, Kidney international,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
September 1995, Diabetologia,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
February 1994, The Journal of physiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
September 1994, Pflugers Archiv : European journal of physiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
November 2012, Masui. The Japanese journal of anesthesiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
September 1989, The Journal of physiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
June 2008, Pflugers Archiv : European journal of physiology,
Iskra Cruz-Cruz, and Germán Bernate-Obando, and Carlos Larqué, and Rene Escalona, and Rodolfo Pinto-Almazán, and Myrian Velasco
December 2006, Toxicology,
Copied contents to your clipboard!